PharmaCyte Biotech, Inc. (PMCB)

Biological Products, (No Diagnostic Substances)

Latest Price

$0.58

TTM P/E

Normalized P/E

Div Yield

Book Value

5.00

P/B Ratio

0.12

Valuation metrics

EPS: $3.19

Book value / share: $7.64

Formula: √(22.5 × EPS × BVPS)

Graham Number

$23.41

+3964% upside

EPS: $3.19

Target P/E: 15×

Formula: EPS × P/E

P/E Fair Value

$47.85

+8207% upside

10.2% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
CITADEL ADVISORS LLC	519.7K	--	4.84%	+103.9K	2026-03-31
GEODE CAPITAL MANAGEMENT, LLC	195.7K	--	1.82%	+71.8K	2026-03-31
RENAISSANCE TECHNOLOGIES LLC	56.5K	--	0.53%	-37.5K	2026-03-31
XTX Topco Ltd	52.4K	--	0.49%	+27.9K	2026-03-31
VANGUARD CAPITAL MANAGEMENT LLC	51.5K	--	0.48%	--	2026-03-31
Virtu Financial LLC	37.5K	--	0.35%	--	2026-03-31
NORTHERN TRUST CORP	35.6K	--	0.33%	--	2026-03-31
Schonfeld Strategic Advisors LLC	27.0K	--	0.25%	+831	2026-03-31
HRT FINANCIAL LP	24.7K	--	0.23%	-158.1K	2026-03-31
VANGUARD FIDUCIARY TRUST CO	23.5K	--	0.22%	--	2026-03-31